FIELD: organic chemistry, heterocyclic compounds, pharmacy. SUBSTANCE: invention relates to novel 3-substituted derivatives of 3,4,5,6,7,8-hexa-hydropyrido-[4', 3': 4,5] -thieno- [2,3-d]-pyrimidine of the general formula (I) and their physiologically acceptable salts exhibiting selective effect of antagonists of 5HT1B and 5HT1A and eliciting inhibitory effect of serotonin reuptake. Compounds can be used for preparing medicinal agents, in part, agents used for treatment of patients with depressions and related diseases. In compounds of the formula (I) R1 means hydrogen atom, alkyl with 1-4 carbon atoms, acetyl or benzoyl group, phenylalkyl residue with 1-4 carbon atoms in alkyl moiety being aromatic fragment can be substituted with halogen atom, alkyl with 1-4 carbon atoms, trifluoromethyl group, hydroxyl group, alkoxy-group with 1-4 carbon atoms, amino-group, cyano-group or nitro-group, naphthyl-alkyl residue with 1-3 carbon atoms in alkyl moiety, phenylalkanone residue with 2-3 carbon atoms in alkane moiety or phenylcarbamoyl-alkyl residue with 2 carbon atoms in alkyl moiety being phenyl group can be substituted with halogen atom; R2 means unsubstituted phenyl, pyridyl, pyrimidinyl or pyrazinyl group or these groups can be mono-, di- or trisubstituted with halogen atom, alkyl with 1-4 carbon atoms, trifluoromethyl, trifluoromethoxyl, hydroxyl groups, alkoxy-groups with 1-4 carbon atoms, amino-groups, monomethylamino-groups, dimethyl-amino-, cyano- or nitro- groups being these groups can be anellated with six-membered aromatic ring that can comprise one or two substituted taken among halogen atom, alkyl with 1-4 carbon atoms, hydroxyl group, trifluoromethyl group, alkoxy-group with 1-4 carbon atoms, amino-group, cyano-group or nitro-group and if necessary it can comprise one nitrogen atom or with 5- or 6-membered ring that can comprise 1-2 oxygen atoms or can be substituted with phenylalkyl group or phenylalkoxy-group with 1-2 carbon atoms in alkyl moiety being phenyl residue can be substituted with halogen atom, methyl group, trifluoromethyl group or methoxy-group; A means imino-group or oxygen atom; B means hydrogen atom or methyl group; C means hydrogen atom, methyl group or hydroxyl group; X means nitrogen atom; Y means CH2,CH2-CH2,CH2-CH2-CH2 or CH2-CH; Z means nitrogen atom, carbon atom or CH being a bond between Y and Z can be double also; n means a number 2, 3 or 4. Invention relates also to their physiologically acceptable salts. EFFECT: valuable medicinal properties of compounds. 6 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
0 |
|
SU504492A3 | |
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
SUBSTITUTED PYRIDO[4',3':5,6]PYRANO[2,3-d]PYRIMIDINES AND COMBINATORY LIBRARY | 2004 |
|
RU2269538C1 |
THIENOPYRIMIDINE COMPOUNDS AND THEIR APPLICATION | 2004 |
|
RU2331648C2 |
DERIVATIVES OF PIPERAZINE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUND | 1992 |
|
RU2193561C2 |
SUBSTITUTED 3-CYANOTIOPHENACETAMIDES AS GLUCAGON RECEPTOR ANTAGONISTS | 2004 |
|
RU2336274C2 |
METHOD OF PRODUCING DERIVATIVES OF 4,5,6,7-TETRAHYDROTHIENO(2,3-C)PYRIDINE | 0 |
|
SU628820A3 |
3-HALOGEN-3-HETARYLCARBOXYLIC ACID DERIVATIVES, AND HERBICIDAL AGENT | 1994 |
|
RU2146255C1 |
POLY(ADP-RIBOSO)POLYMERASE INHIBITORS | 2007 |
|
RU2455286C2 |
PYRIMIDINE DERIVATIVES AND METHODS OF PREPARING THEREOF | 1995 |
|
RU2129549C1 |
Authors
Dates
2003-02-20—Published
1997-08-22—Filed